Pazit Enker Ohana is an operations executive with over 15 years of leadership experience across public and private medtech and biotechnology companies. She brings extensive expertise in global operations spanning the US, Europe, and Asia, including business development, licensing, strategic partnerships, and execution of complex strategic initiatives.
Prior to joining Averna Therapeutics, Pazit served as CEO of BioCEP Ltd. and previously held the position of Senior Director at Orgenesis (NASDAQ: ORGS), where she led global operational and strategic initiatives.
Pazit holds a B.Sc. in Biotechnology Engineering from ORT Braude College and an MBA from The College of Management Academic Studies.